Are Biological Doublets the Future of Adjuvant Therapy after surgery for Renal Cell Carcinoma?

Journal of Urology · Published 2026-08-04 · DOI 10.1097/ju.0000000000005245

Authors (2)

Riccardo Bertolo, Alessandro Antonelli

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Bertolo, R., Antonelli, A. (2026). Are Biological Doublets the Future of Adjuvant Therapy after surgery for Renal Cell Carcinoma?. Journal of Urology. https://doi.org/10.1097/ju.0000000000005245

Related articles